GlassScriptPhysician profile
Abdur Rehman
NPI 1427280965
$6,961.26
in general payments reported to CMS, 2019-2025
10 companies · $501 in 2025
The $501 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $229 · 2021: $174 · 2022: $2,624 · 2023: $3,083 · 2024: $206 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,902 · Travel and Lodging: $1,888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,902.33 |
| Travel and Lodging | $1,888.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,018.37 | 2021-2023 | Optis, Supera |
| Abiomed | $917.91 | 2022-2024 | Impella |
| Medtronic Vascular, INC. | $210.65 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $162.45 | 2019-2020 | |
| Surmodics, INC. | $151.05 | 2024 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| W. L. Gore & Associates, INC. | $139.96 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Stryker Corporation | $132.20 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $124.53 | 2025 | Ranger |
| Penumbra, INC. | $87.47 | 2025 | Indigo System |
| Amgen INC. | $16.67 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdur Rehman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.